Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 434

1.

Diagnostic accuracy of 18 F-FDG and 11 C-PIB-PET for prediction of short-term conversion to Alzheimer's disease in subjects with mild cognitive impairment.

Zhang S, Han D, Tan X, Feng J, Guo Y, Ding Y.

Int J Clin Pract. 2012 Feb;66(2):185-98. doi: 10.1111/j.1742-1241.2011.02845.x. Review.

PMID:
22257044
[PubMed - indexed for MEDLINE]
2.

18F-FDG PET/CT and PET for evaluation of pathological response to neoadjuvant chemotherapy in breast cancer: a meta-analysis.

Cheng X, Li Y, Liu B, Xu Z, Bao L, Wang J.

Acta Radiol. 2012 Jul;53(6):615-27. doi: 10.1258/ar.2012.110603. Epub 2012 Jun 25.

PMID:
22734080
[PubMed - indexed for MEDLINE]
3.

Comparison of 18F-FDG PET/CT with bone scintigraphy for detection of bone metastasis: a meta-analysis.

Cheng X, Li Y, Xu Z, Bao L, Li D, Wang J.

Acta Radiol. 2011 Sep 1;52(7):779-87. doi: 10.1258/ar.2011.110115. Epub 2011 Jun 28.

PMID:
21712464
[PubMed - indexed for MEDLINE]
4.

[11C]PIB, [18F]FDG and MR imaging in patients with mild cognitive impairment.

Brück A, Virta JR, Koivunen J, Koikkalainen J, Scheinin NM, Helenius H, Någren K, Helin S, Parkkola R, Viitanen M, Rinne JO.

Eur J Nucl Med Mol Imaging. 2013 Oct;40(10):1567-72. doi: 10.1007/s00259-013-2478-8. Epub 2013 Jun 26.

PMID:
23801168
[PubMed - indexed for MEDLINE]
5.

(11)C-PIB-PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).

Zhang S, Smailagic N, Hyde C, Noel-Storr AH, Takwoingi Y, McShane R, Feng J.

Cochrane Database Syst Rev. 2014 Jul 23;7:CD010386. doi: 10.1002/14651858.CD010386.pub2.

PMID:
25052054
[PubMed - in process]
6.

Prediction of tumor response to neoadjuvant therapy in patients with esophageal cancer with use of 18F FDG PET: a systematic review.

Kwee RM.

Radiology. 2010 Mar;254(3):707-17. doi: 10.1148/radiol.09091324. Review.

PMID:
20177086
[PubMed - indexed for MEDLINE]
7.

Evidence for astrocytosis in prodromal Alzheimer disease provided by 11C-deuterium-L-deprenyl: a multitracer PET paradigm combining 11C-Pittsburgh compound B and 18F-FDG.

Carter SF, Schöll M, Almkvist O, Wall A, Engler H, Långström B, Nordberg A.

J Nucl Med. 2012 Jan;53(1):37-46. doi: 10.2967/jnumed.110.087031.

PMID:
22213821
[PubMed - indexed for MEDLINE]
Free Article
8.
9.

18 F-fluorodeoxyglucose positron emission tomography to evaluate recurrent gastric cancer: a systematic review and meta-analysis.

Wu LM, Hu JN, Hua J, Gu HY, Zhu J, Xu JR.

J Gastroenterol Hepatol. 2012 Mar;27(3):472-80. doi: 10.1111/j.1440-1746.2011.06919.x. Review.

PMID:
21916986
[PubMed - indexed for MEDLINE]
10.

18F-FDG PET for evaluation of bone marrow infiltration in staging of lymphoma: a meta-analysis.

Pakos EE, Fotopoulos AD, Ioannidis JP.

J Nucl Med. 2005 Jun;46(6):958-63.

PMID:
15937306
[PubMed - indexed for MEDLINE]
Free Article
11.

Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer's disease.

Li Y, Rinne JO, Mosconi L, Pirraglia E, Rusinek H, DeSanti S, Kemppainen N, Någren K, Kim BC, Tsui W, de Leon MJ.

Eur J Nucl Med Mol Imaging. 2008 Dec;35(12):2169-81. doi: 10.1007/s00259-008-0833-y. Epub 2008 Jun 20.

PMID:
18566819
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Dynamic changes in PET amyloid and FDG imaging at different stages of Alzheimer's disease.

Kadir A, Almkvist O, Forsberg A, Wall A, Engler H, Långström B, Nordberg A.

Neurobiol Aging. 2012 Jan;33(1):198.e1-14. doi: 10.1016/j.neurobiolaging.2010.06.015. Epub 2010 Aug 4.

PMID:
20688420
[PubMed - indexed for MEDLINE]
13.

Longitudinal imaging of Alzheimer pathology using [11C]PIB, [18F]FDDNP and [18F]FDG PET.

Ossenkoppele R, Tolboom N, Foster-Dingley JC, Adriaanse SF, Boellaard R, Yaqub M, Windhorst AD, Barkhof F, Lammertsma AA, Scheltens P, van der Flier WM, van Berckel BN.

Eur J Nucl Med Mol Imaging. 2012 Jun;39(6):990-1000. doi: 10.1007/s00259-012-2102-3. Epub 2012 Mar 23.

PMID:
22441582
[PubMed - indexed for MEDLINE]
14.

Diagnosed mild cognitive impairment due to Alzheimer's disease with PET biomarkers of beta amyloid and neuronal dysfunction.

Hatashita S, Yamasaki H.

PLoS One. 2013 Jun 14;8(6):e66877. doi: 10.1371/journal.pone.0066877. Print 2013.

PMID:
23799136
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Can ¹⁸F-fluorodeoxyglucose positron emission tomography predict responses to neoadjuvant therapy in oesophageal cancer patients? A meta-analysis.

Chen YM, Pan XF, Tong LJ, Shi YP, Chen T.

Nucl Med Commun. 2011 Nov;32(11):1005-10. doi: 10.1097/MNM.0b013e32834a8366.

PMID:
21886014
[PubMed - indexed for MEDLINE]
16.

Systematic review of the diagnostic accuracy of (18)F-fluorodeoxyglucose positron emission tomography in melanoma patients.

Mijnhout GS, Hoekstra OS, van Tulder MW, Teule GJ, Devillé WL.

Cancer. 2001 Apr 15;91(8):1530-42.

PMID:
11301402
[PubMed - indexed for MEDLINE]
17.

18F-fluorodeoxyglucose positron emission tomography to evaluate cervical node metastases in patients with head and neck squamous cell carcinoma: a meta-analysis.

Kyzas PA, Evangelou E, Denaxa-Kyza D, Ioannidis JP.

J Natl Cancer Inst. 2008 May 21;100(10):712-20. doi: 10.1093/jnci/djn125. Epub 2008 May 13.

PMID:
18477804
[PubMed - indexed for MEDLINE]
Free Article
18.

Automated analysis of FDG PET as a tool for single-subject probabilistic prediction and detection of Alzheimer's disease dementia.

Arbizu J, Prieto E, Martínez-Lage P, Martí-Climent JM, García-Granero M, Lamet I, Pastor P, Riverol M, Gómez-Isla MT, Peñuelas I, Richter JA, Weiner MW; Alzheimer's Disease Neuroimaging Initiative.

Eur J Nucl Med Mol Imaging. 2013 Sep;40(9):1394-405. doi: 10.1007/s00259-013-2458-z. Epub 2013 May 29.

PMID:
23715905
[PubMed - indexed for MEDLINE]
19.

Diagnostic accuracy of ¹⁸F-FDG-PET and PET/CT in patients with Ewing sarcoma family tumours: a systematic review and a meta-analysis.

Treglia G, Salsano M, Stefanelli A, Mattoli MV, Giordano A, Bonomo L.

Skeletal Radiol. 2012 Mar;41(3):249-56. doi: 10.1007/s00256-011-1298-9. Epub 2011 Nov 10. Review.

PMID:
22072239
[PubMed - indexed for MEDLINE]
20.

Quantitative longitudinal interrelationships between brain metabolism and amyloid deposition during a 2-year follow-up in patients with early Alzheimer's disease.

Förster S, Yousefi BH, Wester HJ, Klupp E, Rominger A, Förstl H, Kurz A, Grimmer T, Drzezga A.

Eur J Nucl Med Mol Imaging. 2012 Dec;39(12):1927-36. doi: 10.1007/s00259-012-2230-9. Epub 2012 Aug 28.

PMID:
22926714
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk